Case report: Liquid biopsy, the sooner the better?

The detection of circulating tumor DNA (ctDNA) by liquid biopsy is taking an increasing role in thoracic oncology management due to its predictive and prognostic value. For non-small cell lung cancer, it allows the detection of molecular mutations that can be targeted with tyrosine kinase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Quentin Dominique, Colard-Thomas, Julien, Delansay, Delphine, Leenhardt, Fanny, Solassol, Jerome, Vendrell, Julie A., Quantin, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797958/
https://www.ncbi.nlm.nih.gov/pubmed/36591516
http://dx.doi.org/10.3389/fonc.2022.1089108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797958/
https://www.ncbi.nlm.nih.gov/pubmed/36591516
http://dx.doi.org/10.3389/fonc.2022.1089108

Ejemplares similares